EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of flavonoids from natural products against hyperlipidaemia through computational approaches

Nurnazira Hanis Mustaffar Kamal, Nurul Azira Ismail iD, Ernie Zuraida Ali

PLOS One · 2026

DOI: 10.1371/journal.pone.0346073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Nurnazira Hanis Mustaffar Kamal und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Graduate Studies, Postgraduate Centre Management and Science University, University Drive, Shah Alam, Selangor, Malaysia. Hauptthemen laut MEDLINE: Flavonoids, Biological Products, Hyperlipidemias. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Management and Science University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the centuries, hyperlipidaemia has been recognised as a major risk factor contributing to cardiovascular disease (CVD). Current research increasingly explores natural compounds such as flavonoids for their potential lipid-lowering effects. This study evaluated pharmacological potential of flavonoids to identify strong inhibitors for target receptor, Proprotein Convertase Subtilisin/Kexin Type (PCSK9). A total of 29 compounds, including one FDA-approved drugs were screened for drug-likeness and ADMET properties, followed by molecular docking and Molecular Dynamics (MD) simulations using PCSK9 receptor containing glucose and sodium (PDB ID: 5OCA). This complex was chosen due to their functional relevance to cholesterol metabolism. As a results, 24 compounds satisfied Lipinski’s Rule of Five and exhibited favourable drug-likeness and toxicity profiles. Simvastatin (control) was discovered to bind into the pocket B binding site along with seven flavonoids; Diosmetin, Eupatorin, Isorhamnetin, Myricetin, Petunidin, Sinensetin, and Tilianin. These flavonoids displayed docking energies ranging from −8.0 to −10.2 kcal/mol. Tilianin showed the strongest affinity (−10.2 kcal/mol), while Simvastatin bound with −9.1 kcal/mol. MD simulations confirmed that the PCSK9-ligand complexes remained structurally stable throughout a 100 ns trajectory. MM/PBSA analysis further supported the binding interactions, revealing free energies values ranging from −17 to −30.41 kcal/mol. Among the flavonoids evaluated, Tilianin, Myricetin, and Sinensetin demonstrate the most favourable interaction profiles. These finding suggest that the selected flavonoids have strong potential as promising anti-hyperlipidaemic candidates targeting PCSK9.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavonoidsBiological ProductsHyperlipidemiasMolecular Docking SimulationProprotein Convertase 9Molecular Dynamics SimulationHumansPCSK9 InhibitorsBinding SitesSimvastatin

Substanzen

FlavonoidsProprotein Convertase 9Biological ProductsPCSK9 protein, humanPCSK9 InhibitorsSimvastatin

Autor:innen und Institutionen

  • School of Graduate Studies, Postgraduate Centre Management and Science University, University Drive, Shah Alam, Selangor, Malaysia.
  • Faculty of Health and Life Sciences, Management and Science University, University Drive, Shah Alam, Selangor, Malaysia.
  • Institute for Medical Research, National Institutes of Health Malaysia, Shah Alam, Selangor, Malaysia.

ORCID-Profile: Nurul Azira Ismail

Förderung

  • Management and Science University

Zitieren

APA

Mustaffar Kamal, N. H., Ismail, N. A., & Ali, E. Z. (2026). Identification of flavonoids from natural products against hyperlipidaemia through computational approaches. PLOS One. https://doi.org/10.1371/journal.pone.0346073

Vancouver

Mustaffar Kamal NH, Ismail NA, Ali EZ. Identification of flavonoids from natural products against hyperlipidaemia through computational approaches. PLOS One. 2026. doi:10.1371/journal.pone.0346073

BibTeX
@article{MustaffarKamal2026,
  author = {Mustaffar Kamal, Nurnazira Hanis and Ismail, Nurul Azira and Ali, Ernie Zuraida},
  title = {Identification of flavonoids from natural products against hyperlipidaemia through computational approaches},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0346073}
}
Kostenlos starten →